Antimicrobial Resistance Patterns Among Acinetobacter Baumannii Isolated From Burn Intensive Care Unit In Tripoli, Libya

International Arabic Journal of Antimicrobial Agents

Volumn 2, Issue 3, 2012, Pages

  Ziglam, Hisham ^a   Elahmer, Omar ^b   Amri, Samira ^c   Shareef, Fatima ^c   Grera, Ali ^c   Labeeb, Mohamed ^d   Zorgani, Abdulaziz ^d  

^a TRIPOLI CENTRAL HOSPITAL   (Libyan Arab Jamahiriya)

^b National Centre of Diseases Control   (Libyan Arab Jamahiriya)

^c Burns and Plastic Surgery Centre   (Libyan Arab Jamahiriya)

^d UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

Acinetobacter baumannii; Burns

Indexed keywords

EID: 84886925631     PISSN: None     EISSN: 21749094     Source Type: Journal    
DOI: 10.3823/716     Document Type: Article

References (41)

1. S. El Shafe, M. Alishaq and M. Leni Garcia. Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit. J Hosp Infect. 2004. 56: 101-105.
2. P. Fournier and H. Richet. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006. 42: 692-699.
3. L. Munoz-Price and R. Weinstein. Acinetobacter infection. N Engl J Med. 2008. 358: 1271-1281.
4. H. Richet and P. Fournier. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect Control Hosp Epidemiol. 2006. 27: 645-646.
5. A. Abbo, S. Navon-Venezia, O. Hammer-Muntz, T. Krichali, Y. Siegman-Igra and Y. Carmeli. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis. 2005. 11: 22-29.
6. S. Lockhart, M. Abramson, S. Beekmann, et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol. 2007. 45: 3352-3359.
7. J. Coelho, J. Turton, M. Kaufmann, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol. 2006. 44: 3623-3627.
8. Y. Kim, S. Kim, Y. Kim, et al. Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection. Epidemiol Infect. 2011. 1-9.
9. A. Nemec, L. Krízová, M. Maixnerová, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother. 2008. 62: 484-489.
10. C. Héritier, L. Poirel, P. Fournier, J. Claverie, D. Raoult and P. Nordmann. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother. 2005. 49: 4174-4179.
11. Clinical laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100-S19. Wayne, PA: CLSI. 2009.
12. M. Devaud, F. Kayser and B. Bächi. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother. 1982. 22: 323-329.
13. P. Fournier, D. Vallenet, V. Barbe, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006. 2: e7.
14. K. Lee, D. Yong, S. Jeong and Y. Chong. Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens. Yonsei Med J. 2011. 52: 879-891.
15. H. Segal, R. Thomas and B. Gay Elisha. Characterization of class 1 integron resistance gene cassettes and the identifcation of a novel IS-like element in Acinetobacter baumannii. Plasmid. 2003. 49: 169-178.
16. H. Seifert, B. Boullion, A. Schulze and G. Pulverer. Plasmid DNA profiles of Acinetobacter baumannii: clinical application in a complex endemic setting. Infect Control Hosp Epidemiol. 1994. 15: 520-528.
17. J. Ye, C. Huang, S. Shie, et al. Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains. PLoS One. 2010. 5: e9947.
18. E. Bergogne-Bérézin and K. Towner. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996. 9: 148-165.
19. M. Falagas, S. Kasiakou and A. Michalopoulos. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect. 2004. 10: 1106-1107.
20. P. Nordmann and L. Poirel. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect. 2002. 8: 321-331.
21. C. Wu, H. Lee, N. Lee, et al. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect. 2006. 39: 135-143.
22. Y. Ishii, J. Alba, S. Kimura and K. Yamaguchi. Evaluation of antimicrobial activity of beta-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis. 2006. 55: 143-148.
23. J. Al-Tawfq and T. Mohandhas. Prevalence of antimicrobial resistance in Acinetobacter calcoaceticus-baumannii complex in a Saudi Arabian hospital. Infect Control Hosp Epidemiol. 2007. 28: 870-872.
24. A. Gales, R. Jones, K. Forward, J. Liñares, H. Sader and J. Verhoef. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis. 2001. 32 Suppl 2: S104-S113.
25. P. Turner and J. Greenhalgh. The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect. 2003. 9: 563-567.
26. P. Turner. Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis. 2008. 60: 185-192.
27. L. McDonald. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis. 2006. 42 Suppl 2: S65-S71.
28. M. Falagas, E. Mourtzoukou, M. Polemis and A. Vatopoulos. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications. Clin Microbiol Infect. 2007. 13: 816-819.
29. X. Meng, M. Dong, D. Wang, et al. Antimicrobial susceptibility patterns of clinical isolates of gram-negative bacteria obtained from intensive care units in a tertiary hospital in Beijing, China. J Chemother. 2011. 23: 207-210.
30. S. Irfan, J. Turton, J. Mehraj, et al. Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. J Hosp Infect. 2011. 78: 143-148.
31. Z. Hu, Z. Wang, D. Liu, et al. Clinical and molecular microbiological characteristics of carbapenem-resistant Acinetobacter baumannii strains in a NICU. Pediatr Int. 2011.
32. C. He, Y. Xie, L. Zhang, et al. Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit. J Med Microbiol. 2011. 60: 337-341.
33. M. Dizbay, A. Altuncekic, B. Sezer, K. Ozdemir and D. Arman. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia. Int J Antimicrob Agents. 2008. 32: 29-32.
34. M. G. Savov E, Borisova M. Multidrug resistant Acinetobacter baumannii: a major concern in the hospital setting. Trakia Journal of Sciences. 2008. 6:
35. D. Wareham, D. Bean, P. Khanna, et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008. 27: 607-612.
36. J. Cisneros, J. Rodríguez-Baño, F. Fernández-Cuenca, et al. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin Microbiol Infect. 2005. 11: 874-879.
37. L. Dent, D. Marshall, S. Pratap and R. Hulette. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis. 2010. 10: 196.
38. H. Onarheim, T. Høivik, S. Harthug, A. Digranes, H. Mylvaganam and H. Vindenes. [Outbreak of multiresistant Acinetobacter baumannii infection]. Tidsskr Nor Laegeforen. 2000. 120: 1028-1033.
39. J. Turton, M. Kaufmann, M. Gill, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq confict. J Clin Microbiol. 2006. 44: 2630-2634.
40. I. Wybo, L. Blommaert, T. De Beer, et al. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece. J Hosp Infect. 2007. 67: 374-380.
41. A. Peleg, C. Franklin, J. Bell and D. Spelman. Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia. Infect Control Hosp Epidemiol. 2006. 27: 759-761.